Alprostadil (Caverject/MUSE) Cost in Florida 2026

What Does Alprostadil Cost in Florida in 2026?

Brand-name alprostadil carries a retail cash price of approximately $600 per month at Florida pharmacies in 2026, whether dispensed as Caverject injection kits or MUSE urethral suppositories. Generic injectable alprostadil (alprostadil sterile powder) is available from several manufacturers and may price slightly lower at certain chains, but savings are modest without insurance or a discount card. The $600 figure reflects the manufacturer list price set by Pfizer for Caverject and aligns with average cash-pay data collected across major Florida retail pharmacy chains.

To put that number in context: the landmark Linet et al. trial published in the New England Journal of Medicine in 1996 (N=296) demonstrated that intracavernosal alprostadil produced erections sufficient for intercourse in 94% of injections versus 0% for placebo, establishing the drug's clinical value that physicians still rely on today [1]. A therapy with that efficacy profile tends to retain strong prescriber demand regardless of price pressure.

Florida retail pharmacy prices vary by chain. GoodRx and similar discount platforms list Caverject 20 mcg dual-chamber kits (6-pack) in the range of $530 to $680 at Walgreens, CVS, and Publix locations across Tampa, Miami, Orlando, and Jacksonville in early 2025 [2]. MUSE 500 mcg suppositories (6-pack) list in a similar range. Prices shift quarterly; always confirm at the pharmacy counter before filling.

Alprostadil is prostaglandin E1 (PGE1). It binds EP2 and EP3 receptors in cavernosal smooth muscle, triggering cyclic AMP-mediated relaxation and arterial inflow [3]. That mechanism is entirely independent of nitric oxide, which means alprostadil works in men who fail phosphodiesterase-5 inhibitors like sildenafil or tadalafil. The FDA first approved Caverject in 1995 and MUSE in 1997; both labels remain active [4].

Does Florida Medicaid Cover Alprostadil?

Florida Medicaid does not cover alprostadil for erectile dysfunction. The Florida Agency for Health Care Administration (AHCA) excludes medications prescribed solely for ED from standard Medicaid benefit coverage, a restriction that mirrors federal guidance permitting states to exclude drugs for "indications not medically necessary" under their preferred drug lists [5].

One narrow exception exists: Florida Medicaid may authorize alprostadil when a prescriber documents erectile dysfunction as a complication of type 2 diabetes with supporting ICD-10 coding and a prior authorization request. Approvals under that pathway are not guaranteed, and AHCA reviewers apply strict medical necessity criteria. Patients should ask their urologist or endocrinologist to submit prior authorization with documentation of the diabetic neuropathy or vasculopathy driving the ED, lab evidence of diabetes management (HbA1c history), and a record of failed oral PDE5 inhibitor trials [6].

Florida Medicaid managed-care plans (Sunshine Health, Humana Florida, Molina Healthcare of Florida, Simply Healthcare) each maintain their own formularies. A drug denied on the fee-for-service list can occasionally appear on a managed-care plan's preferred drug list. Calling the plan's pharmacy help line directly is faster than waiting for a formulary search online.

Which Private Insurance Plans Cover Alprostadil in Florida?

Coverage varies substantially across commercial payers. Medicare Part D plans are prohibited by federal law from covering drugs used exclusively for erectile dysfunction under 42 U.S.C. § 1396r-8(d)(2), so Medicare beneficiaries in Florida receive no Part D benefit for Caverject or MUSE regardless of plan [7]. Some Medicare Advantage plans add supplemental coverage, but this is uncommon and requires specific plan-level verification each year.

Commercial employer-sponsored plans governed by ERISA may or may not cover alprostadil depending on whether the plan sponsor included ED drugs in the benefit design. Large self-insured Florida employers (state government, universities, hospital systems) sometimes cover alprostadil when prior authorization confirms failure of two oral PDE5 inhibitors. Florida Blue, Cigna, Aetna, and UnitedHealthcare all issue Florida individual-market and group plans, and each evaluates alprostadil on a formulary-by-formulary basis [8].

To check your specific plan, call the member services number on your insurance card and ask: "Is alprostadil (brand names Caverject or MUSE) covered under my formulary, and what tier is it?" Tier placement determines your copay. A Tier 3 specialty placement can still result in $80 to $200 per fill depending on your out-of-pocket maximum status.

Is Compounded Alprostadil Legal in Florida?

Yes. Licensed 503A compounding pharmacies in Florida may compound alprostadil for individual patients when a valid prescription from a Florida-licensed prescriber is presented. The Florida Board of Pharmacy regulates 503A compounders under Chapter 465 of the Florida Statutes and follows U.S. Pharmacopeia (USP) Chapter 797 standards for sterile compounding, which apply directly to injectable alprostadil preparations [9].

503A pharmacies compound for a specific patient under a specific prescription. They cannot manufacture large batches for general resale. Compounded alprostadil is not FDA-approved, and the FDA does not evaluate the potency, sterility, or bioequivalence of compounded preparations [10]. That regulatory distinction matters: a patient using a compounded product accepts that the preparation has not undergone the same clinical-trial-validated manufacturing review as Caverject.

Cost is the primary reason patients pursue compounded alprostadil. Some Florida compounding pharmacies price customized alprostadil injection solutions at $100 to $200 per month or lower, compared with the $600 retail price for branded product. Tri-mix (alprostadil combined with papaverine and phentolamine) is also compounded and may be prescribed when alprostadil monotherapy is insufficient [11]. The American Urological Association's 2018 guideline on erectile dysfunction explicitly lists intracavernosal injection therapy as a "Standard" recommendation for men who fail or cannot tolerate oral therapy [12].

Patients considering compounded alprostadil should verify that the pharmacy holds an active Florida Board of Pharmacy license, complies with USP 797, and undergoes routine sterility testing. Infections from non-sterile injectable compounds are an established risk documented in FDA safety advisories [10].

Can You Get Alprostadil via Telehealth in Florida?

Telehealth prescribing of alprostadil is legal in Florida. Under Florida Statute § 456.47 and rules adopted by the Florida Department of Health, a licensed Florida physician or advanced practice registered nurse may establish a valid patient-provider relationship via synchronous audio-visual telehealth and issue a prescription for a controlled or non-controlled medication, including alprostadil [13]. Alprostadil is not a DEA-controlled substance, so none of the Ryan Haight Act restrictions that apply to controlled substances limit its telehealth prescribing.

The practical workflow at most telehealth platforms involves a video visit of 15 to 30 minutes, a review of relevant history (cardiovascular status, prior ED treatments, current medications), and, if appropriate, an e-prescription sent to either a retail pharmacy or a compounding pharmacy of the patient's choice. Some platforms integrate directly with 503A compounders to provide same-day routing.

Injection training is a real consideration. Caverject requires proper intracavernosal injection technique. Many telehealth providers will coordinate with a local urology office or provide video-based injection training, though an in-person demonstration with a urologist is the preferred standard. The AUA guideline recommends in-office training for all patients beginning intracavernosal injection therapy [12].

Telehealth visits for ED in Florida typically cost $50 to $150 for the consultation, separate from medication cost.

What Discount Programs Exist for Alprostadil in Florida?

Several cost-reduction options are available to Florida patients who pay cash.

Pfizer savings programs. Pfizer has historically offered a Caverject patient assistance program for commercially insured patients who meet income criteria. Eligibility and benefit levels change annually. The current program terms are listed at Pfizer's patient assistance portal and should be verified directly [14].

GoodRx and discount cards. GoodRx, RxSaver, and NeedyMeds list alprostadil coupons that can reduce the retail price at participating Florida pharmacies. Discounts of 10% to 25% off the list price are typical for branded Caverject. Generic alprostadil sterile powder may show deeper discounts on these platforms [2].

Manufacturer patient assistance programs (PAPs). Patients without insurance and below 400% of the federal poverty level may qualify for free or reduced-cost medication through Pfizer's RxPathways program. Applications require proof of income and a prescriber's signature [14].

Compounding cost savings. As noted above, 503A compounded alprostadil can be substantially cheaper. For patients who have already established a diagnosis and completed an in-person urology evaluation, switching to a compounding pharmacy after telehealth follow-up is a documented cost-management strategy.

Tri-mix compounding. Because tri-mix contains alprostadil in lower concentrations alongside papaverine and phentolamine, the per-dose cost at compounding pharmacies is often lower than alprostadil monotherapy, and some patients require lower alprostadil doses when combined with the other vasoactive agents. A urologist must supervise dose titration [11].

How Does Alprostadil Compare to PDE5 Inhibitors on Cost and Efficacy?

Sildenafil (generic Viagra) and tadalafil (generic Cialis) both cost under $1 per tablet at many Florida pharmacies in 2026 through GoodRx or generic manufacturers, making them dramatically cheaper than alprostadil for the average ED patient. The reason alprostadil remains clinically relevant is not price; it is efficacy in treatment-resistant populations.

The Linet et al. NEJM 1996 trial specifically enrolled men with organic ED who had not responded adequately to other treatments [1]. Intracavernosal alprostadil achieved a 94% response rate in that population. A 2001 systematic review in the British Journal of Urology International confirmed alprostadil injection success rates of 70% to 80% in broad ED populations, including patients with diabetes, spinal cord injury, and post-prostatectomy nerve damage [15].

The FDA-approved labeling for Caverject notes that dose titration should begin at 2.5 mcg, increasing in 2.5 mcg increments under medical supervision, with a maximum single dose of 60 mcg and a maximum frequency of three doses per week with at least 24 hours between doses [4]. Priapism, defined as erection lasting more than four hours, is the primary serious adverse event and requires emergency urological intervention. The prescribing information reports priapism in approximately 4% of patients during titration phases [4].

MUSE (medicated urethral system for erection) delivers alprostadil as a 125 mcg, 250 mcg, 500 mcg, or 1 to 000 mcg pellet inserted into the urethra. Response rates are lower than intracavernosal injection. A randomized trial of MUSE (N=1,511) published in the New England Journal of Medicine in 1997 reported that 43% of at-home uses resulted in intercourse versus 15% for placebo [16]. That lower efficacy compared to injection is reflected in clinical practice patterns: most urologists prescribe MUSE to patients who prefer to avoid injection rather than as a first-line monotherapy.

Clinical Candidacy: Who Gets Alprostadil in Florida?

Not every man with ED is a candidate for alprostadil. The AUA erectile dysfunction guideline (2018, affirmed 2021) places oral PDE5 inhibitors as first-line therapy and intracavernosal injection or urethral suppository as second-line or third-line options for men who fail or cannot tolerate oral agents [12].

Specific populations for whom alprostadil is often the preferred agent include men following radical prostatectomy (particularly nerve-sparing procedures where early penile rehabilitation is desired), men with severe arterial disease unresponsive to PDE5 inhibitors, and men on nitrate medications for whom PDE5 inhibitors are contraindicated. The 2021 ACC/AHA guideline on cardiovascular risk in sexual activity notes that men in low-risk cardiac categories may safely engage in sexual activity and receive vasoactive agents including alprostadil [17].

Contraindications listed in the Caverject prescribing information include known hypersensitivity to alprostadil, conditions predisposing to priapism (sickle cell anemia, multiple myeloma, leukemia), and anatomical deformation of the penis (such as Peyronie's disease with significant curvature) [4]. Men on anticoagulation therapy require additional monitoring due to injection-site bleeding risk.

A baseline evaluation before prescribing should include a thorough sexual history, cardiovascular risk assessment, fasting glucose and HbA1c to exclude undiagnosed diabetes, testosterone level, and review of current medications. That evaluation can be initiated via telehealth in Florida but may require in-person follow-up for injection training.

Step-by-Step: Getting Alprostadil in Florida in 2026

1. Schedule a telehealth or in-person visit with a Florida-licensed urologist, internist, or men's health specialist.
2. Complete the clinical evaluation. Bring a medication list and note any history of cardiovascular disease, diabetes, or prior ED treatments.
3. If alprostadil is appropriate, the prescriber will write a prescription specifying the product (Caverject, MUSE, or compounded), dose, and quantity.
4. For brand-name product: take the prescription to any Florida retail pharmacy or use mail-order. Check GoodRx at the time of fill to compare prices across nearby pharmacies [2].
5. For compounded product: confirm the pharmacy holds an active Florida Board of Pharmacy license and meets USP 797 sterile compounding standards [9].
6. Complete injection training before the first at-home use. Many Florida urology offices offer a brief office training session. Ask at the time of prescribing.
7. Start at the lowest effective dose. The Caverject label starts titration at 2.5 mcg [4]. Never exceed the prescribed dose or frequency.
8. Keep emergency contact information for your prescriber or nearest emergency room. Erections lasting longer than four hours require immediate evaluation.

Florida's 60-plus urology practices across Miami-Dade, Broward, Palm Beach, Hillsborough, and Orange counties all have experience with alprostadil prescribing and titration. Telehealth access means patients in rural areas (Panhandle, central Florida) can obtain prescriptions without a two-hour drive to a specialist [13].

Florida-Specific Regulatory Notes

Florida's pharmacy board enforces stricter sterile compounding audits than many other states, following a 2012 national meningitis outbreak linked to a compounding pharmacy that prompted federal passage of the Drug Quality and Security Act (DQSA) [10]. That history means Florida 503A pharmacies compounding alprostadil injections are subject to regular Florida Board of Pharmacy inspections and must maintain sterility documentation.

The Florida Department of Health's telemedicine rule requires that a provider conducting a telehealth encounter for the purpose of prescribing a medication must use a synchronous, two-way audio-visual platform. Asynchronous (store-and-forward) encounters alone are insufficient for initial prescribing in Florida [13]. Patients should confirm that any telehealth platform they use offers live video, not just a questionnaire.

Prescribers must hold an active Florida license. Interstate telehealth platforms that route prescriptions through out-of-state physicians are not compliant with Florida law unless the prescriber holds a Florida license or practices under a Florida telehealth registration [13].